Beyer, J. (2019). Prognostic factors in metastatic germ‐cell cancer. Andrology, 7(4), pp. 475-478. Wiley 10.1111/andr.12615
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
2019 Andrology Review Beyer Prognostic Factors.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (119kB) |
Determining stage and anticipating prognosis are the two crucial steps after the diagnosis of a germ-cell cancer that both guide subsequent treatment decisions. This review focuses on metastatic disease, which means germ-cell cancers beyond stage I limited to the testis. In the past, major centers developed separate staging and prognostic classifications for metastatic germ-cell cancer, which heavily impaired communication and comparisons across clinical trials. More recently, the classification system of the International Germ-Cell Cancer Collaborative Group (IGCCCG) has found acceptance worldwide and is currently being updated.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Beyer, Jörg |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2047-2919 |
Publisher: |
Wiley |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
31 Oct 2019 14:12 |
Last Modified: |
05 Dec 2022 15:31 |
Publisher DOI: |
10.1111/andr.12615 |
PubMed ID: |
30969027 |
BORIS DOI: |
10.7892/boris.134291 |
URI: |
https://boris.unibe.ch/id/eprint/134291 |
Actions (login required)
 |
Edit item |